**Core Concept**
Teratogenicity refers to the ability of a drug or substance to cause congenital anomalies or birth defects in a developing fetus. This phenomenon is closely related to the critical period of organogenesis, which occurs during the first trimester of pregnancy.

**Why the Correct Answer is Right**
Drugs administered during the first trimester can interfere with the complex process of embryogenesis, leading to teratogenic effects. The first trimester is a critical period of rapid cell division and differentiation, during which the major organs and body systems begin to form. Exposure to teratogenic substances during this time can disrupt normal development and result in congenital anomalies. The mechanisms of teratogenesis involve alterations in gene expression, disruption of signaling pathways, and interference with the normal functioning of cellular processes.

**Why Each Wrong Option is Incorrect**
**Option B:** The second trimester is a period of rapid growth and development, but it is not as critical for organogenesis as the first trimester. Although some teratogenic effects may still occur, the risk is significantly lower compared to the first trimester.
**Option C:** The third trimester is primarily a period of fetal growth and maturation, during which the major organs and body systems have already formed. While some teratogenic effects may still occur, the risk is much lower compared to the first trimester.
**Option D:** The period soon after birth is not a critical period for organogenesis, and exposure to teratogenic substances during this time is unlikely to result in congenital anomalies.

**Clinical Pearl / High-Yield Fact**
A classic example of a teratogen is thalidomide, which was used as a sedative and antiemetic in the 1950s and 1960s. Exposure to thalidomide during the first trimester resulted in severe limb deformities and other congenital anomalies in thousands of children.

✓ Correct Answer: A. First trimester